login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Account
Disclaimer
Affiliate
Contact
Privacy
CEL-SCI CORP (CVM) Stock News
USA
- NYSEARCA:CVM -
US1508377066
-
Common Stock
9.52
USD
0 (0%)
Last: 9/17/2025, 11:11:55 AM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
CVM Latest News, Press Relases and Analysis
All
Press Releases
20 days ago - By: Chartmill
- Mentions:
MB
PSTG
MBRX
OTLK
...
Thursday's session: top gainers and losers
20 days ago - By: Chartmill
- Mentions:
PSTG
MBRX
OTLK
FTHM
...
Let's take a look at the stocks that are in motion in today's session.
19 days ago - By: CEL-SCI Corporation
CEL-SCI Announces Closing of $10 Million Public Offering
20 days ago - By: Benzinga
- Mentions:
MBRX
CGC
PAHC
THAR
...
12 Health Care Stocks Moving In Thursday's Intraday Session
20 days ago - By: Chartmill
- Mentions:
GPRE
SNOW
PAHC
PSTG
...
The market is filled with gapping stocks in Thursday's session.
20 days ago - By: Chartmill
- Mentions:
COO
LPSN
ASTI
NVFY
...
Wondering what's happening in today's pre-market session?
20 days ago - By: Benzinga
- Mentions:
TLX
COO
GLMD
PAHC
...
12 Health Care Stocks Moving In Thursday's Pre-Market Session
21 days ago - By: CEL-SCI Corporation
CEL-SCI Announces Pricing of $10 Million Public Offering
21 days ago - By: CEL-SCI Corporation
CEL-SCI Announces Proposed Public Offering
a month ago - By: CEL-SCI Corporation
CEL-SCI Reports Fiscal Third Quarter 2025 Financial Results
a month ago - By: CEL-SCI Corporation
CEL-SCI’s Multikine Head and Neck Cancer Immunotherapy Breakthrough Medicine Designation Filed in Saudi Arabia: Allows for Patient Access and Reimbursement/Sale Upon Granting of the Designation Which Takes Approximately 60 Days Based on SFDA Timeline
2 months ago - By: CEL-SCI Corporation
CEL-SCI Announces Closing of $5.7 Million Offering Priced At-The-Market Under NYSE American Rules
2 months ago - By: Stocktwits
- Mentions:
VTI
IWC
CEL-SCI Stock Soars On Imminent Partnership With Saudi Arabian Pharma Company For Cancer Drug: Retail’s Thrilled
2 months ago - By: CEL-SCI Corporation
CEL-SCI Announces Pricing of $5.7 Million Offering Priced At-the-Market Under NYSE American Rules
2 months ago - By: CEL-SCI Corporation
CEL-SCI to Sign Partnership Agreement With Leading Saudi Arabian Pharma Company for Multikine in the Treatment of Head & Neck Cancer
3 months ago - By: CEL-SCI Corporation
FDA’s Approval of Keytruda for PD-L1 Positive Head and Neck Cancer Patients Signals a Clear Pathway for CEL-SCI’s Multikine to Address a Major Unmet Need in PD-L1 Negative Cancer Patients
4 months ago - By: CEL-SCI Corporation
CEL-SCI Announces Closing of Public Offering
4 months ago - By: CEL-SCI Corporation
CEL-SCI Announces Pricing of Public Offering
4 months ago - By: CEL-SCI Corporation
CEL-SCI Announces Proposed Public Offering
Please enable JavaScript to continue using this application.